Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
Cibil Report
Get cibil report
My Account
Log In
Log into your account
Offers
Check out pre-approved offers now!
Languages
Chosen Language: English
Do Not Call
Do not call
En
Amkay Products Ltd. Share Price
N/A
1D
1M
3M
6M
1Y
5Y
Day's Range
Day's Range
Low
₹
High
₹
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | N/A | 310.69 |
| Expenses | N/A | N/A |
| PBT | N/A | 35.01 |
| Operating profit | N/A | 0.0 |
| Net profit | N/A | 26.3 |
About Amkay Products Ltd.
| Founded | 2007 |
|---|---|
| Managing Director | Kashyap Pravin Mody |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,57,121.30 | 1,906.65 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,81,396.01 | 6,935.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,48,729.85 | 4,409.05 | 3,102.00 - 3,102.00 |
| Apollo Hospitals Enterprise Ltd. | 1,15,331.11 | 8,080.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,15,240.83 | 1,424.50 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,11,126.23 | 1,343.30 | 1,148.40 - 1,148.40 |
| Mankind Pharma Ltd. | 1,03,056.40 | 2,515.05 | 1,909.70 - 1,909.70 |
| Max Healthcare Institute Ltd. | 1,03,022.72 | 1,068.20 | 903.00 - 903.00 |
| Lupin Ltd. | 1,03,010.73 | 2,261.70 | 1,836.80 - 1,836.80 |
| Zydus Lifesciences Ltd. | 99,737.91 | 1,004.30 | 835.50 - 835.50 |
No Records Found
Latest News
May
19
2026
Posted on May 19th 2026
Bharat Parenterals - Quaterly Results
Net sales declined -29.58% to Rs. 565.37 million from Rs. 802.84 millions.Net profit of the cmpany stood at Rs. 13.76 millions for the quarter ended March 2026 a decline of -39.75% from Rs. 22.84 millions in the same quarter last year.The Operating Profit of the company witnessed a decrease to 44.78 millions from 68.53 millions.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 565.37 | 802.84 | -29.58 | 2340.15 | 3041.34 | -23.06 | 2340.15 | 3041.34 | -23.06 |
| Other Income | 44.44 | 22.58 | 96.81 | 125.52 | 145.48 | -13.72 | 125.52 | 145.48 | -13.72 |
| PBIDT | 44.78 | 68.53 | -34.66 | 336.43 | 481.53 | -30.13 | 336.43 | 481.53 | -30.13 |
| Interest | 5.15 | 14.75 | -65.08 | 34.35 | 47.85 | -28.21 | 34.35 | 47.85 | -28.21 |
| PBDT | 39.63 | 53.78 | -26.31 | 302.08 | 433.68 | -30.34 | 302.08 | 433.68 | -30.34 |
| Depreciation | 20.38 | 18.22 | 11.86 | 83.65 | 70.52 | 18.62 | 83.65 | 70.52 | 18.62 |
| PBT | 19.25 | 35.56 | -45.87 | 218.43 | 363.16 | -39.85 | 218.43 | 363.16 | -39.85 |
| TAX | 5.49 | 12.72 | -56.84 | 58.24 | 98.62 | -40.95 | 58.24 | 98.62 | -40.95 |
| Deferred Tax | -4.42 | -0.54 | 718.52 | -11.34 | -7.20 | 57.50 | -11.34 | -7.20 | 57.50 |
| PAT | 13.76 | 22.84 | -39.75 | 160.19 | 264.54 | -39.45 | 160.19 | 264.54 | -39.45 |
| Equity | 68.92 | 68.92 | 0.00 | 68.92 | 68.92 | 0.00 | 68.92 | 68.92 | 0.00 |
| PBIDTM(%) | 7.92 | 8.54 | -7.21 | 14.38 | 15.83 | -9.20 | 14.38 | 15.83 | -9.20 |
Read More
May
19
2026
Posted on May 19th 2026
Unjha Formulations - Quaterly Results
The Sales for the quarter ended March 2026 of Rs. 33.28 millions rose by 36.45% from Rs. 24.39 millions.The Net Loss for the quarter ended March 2026 is Rs. -7.44 millions as compared to Net Loss of Rs. -4.07 millions of corresponding quarter ended March 2025 Operating profit Margin for the quarter ended March 2026 further decreased to -4.48% as compared to -2.59% of corresponding quarter ended March 2025
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 33.28 | 24.39 | 36.45 | 157.49 | 139.77 | 12.68 | 157.49 | 139.77 | 12.68 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDT | -4.48 | -2.59 | 72.97 | 11.04 | 6.30 | 75.24 | 11.04 | 6.30 | 75.24 |
| Interest | 0.03 | -0.01 | -400.00 | 0.08 | 0.08 | 0.00 | 0.08 | 0.08 | 0.00 |
| PBDT | -4.51 | -2.58 | 74.81 | 10.96 | 6.22 | 76.21 | 10.96 | 6.22 | 76.21 |
| Depreciation | 0.44 | 0.33 | 33.33 | 1.42 | 0.98 | 44.90 | 1.42 | 0.98 | 44.90 |
| PBT | -4.95 | -2.91 | 70.10 | 9.54 | 5.24 | 82.06 | 9.54 | 5.24 | 82.06 |
| TAX | 2.49 | 1.16 | 114.66 | 2.49 | 1.16 | 114.66 | 2.49 | 1.16 | 114.66 |
| Deferred Tax | -0.08 | -0.01 | 700.00 | -0.08 | -0.01 | 700.00 | -0.08 | -0.01 | 700.00 |
| PAT | -7.44 | -4.07 | 82.80 | 7.05 | 4.08 | 72.79 | 7.05 | 4.08 | 72.79 |
| Equity | 44.81 | 44.81 | 0.00 | 44.81 | 44.81 | 0.00 | 44.81 | 44.81 | 0.00 |
| PBIDTM(%) | -13.46 | -10.62 | 26.77 | 7.01 | 4.51 | 55.52 | 7.01 | 4.51 | 55.52 |
Read More
May
19
2026
Posted on May 19th 2026
Strides Pharma Scien - Quaterly Results
The Revenue for the quarter ended March 2026 of Rs. 6057.35 millions grew by 8.95 % from Rs. 5559.58 millions.Profit for the quarter ended March 2026 grew by 1.40% to Rs. 163.53 millions from Rs. 161.28 millions.Operating Profit reported a sharp decline to 783.61 millions from 800.54 millions in the corresponding previous quarter.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 6057.35 | 5559.58 | 8.95 | 21801.35 | 21394.23 | 1.90 | 21801.35 | 21394.23 | 1.90 |
| Other Income | 39.70 | 121.22 | -67.25 | 1230.63 | 461.88 | 166.44 | 1230.63 | 461.88 | 166.44 |
| PBIDT | 783.61 | 800.54 | -2.11 | 4081.07 | 3086.30 | 32.23 | 4081.07 | 3086.30 | 32.23 |
| Interest | 266.62 | 293.60 | -9.19 | 1137.68 | 1459.12 | -22.03 | 1137.68 | 1459.12 | -22.03 |
| PBDT | 516.99 | 506.94 | 1.98 | 2943.39 | 1626.91 | 80.92 | 2943.39 | 1626.91 | 80.92 |
| Depreciation | 251.91 | 223.71 | 12.61 | 912.38 | 846.08 | 7.84 | 912.38 | 846.08 | 7.84 |
| PBT | 265.08 | 283.23 | -6.41 | 2031.01 | 780.83 | 160.11 | 2031.01 | 780.83 | 160.11 |
| TAX | 101.55 | 121.95 | -16.73 | 194.66 | 189.27 | 2.85 | 194.66 | 189.27 | 2.85 |
| Deferred Tax | 45.23 | 174.31 | -74.05 | 24.71 | 203.91 | -87.88 | 24.71 | 203.91 | -87.88 |
| PAT | 163.53 | 161.28 | 1.40 | 1836.35 | 591.56 | 210.42 | 1836.35 | 591.56 | 210.42 |
| Equity | 921.73 | 921.63 | 0.01 | 921.73 | 921.63 | 0.01 | 921.73 | 921.63 | 0.01 |
| PBIDTM(%) | 12.94 | 14.40 | -10.16 | 18.72 | 14.43 | 29.76 | 18.72 | 14.43 | 29.76 |
Read More
May
19
2026
Posted on May 19th 2026
GPT Healthcare - Quaterly Results
The revenue zoomed 24.62% to Rs. 1263.72 millions for the quarter ended March 2026 as compared to Rs. 1014.02 millions during the corresponding quarter last year.Net profit stood at Rs. 145.66 millions compared to Rs. 128.90 millions in the corresponding previous quarter,high by 13.00%.The company reported a good operating profit of 249.96 millions compared to 222.63 millions of corresponding previous quarter.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 1263.72 | 1014.02 | 24.62 | 4725.47 | 4070.91 | 16.08 | 4725.47 | 4070.91 | 16.08 |
| Other Income | 16.28 | 15.73 | 3.50 | 59.51 | 84.94 | -29.94 | 59.51 | 84.94 | -29.94 |
| PBIDT | 249.96 | 222.63 | 12.28 | 901.34 | 918.48 | -1.87 | 901.34 | 918.48 | -1.87 |
| Interest | 21.82 | 10.17 | 114.55 | 82.40 | 34.71 | 137.40 | 82.40 | 34.71 | 137.40 |
| PBDT | 228.14 | 212.46 | 7.38 | 818.94 | 883.77 | -7.34 | 818.94 | 883.77 | -7.34 |
| Depreciation | 69.49 | 48.77 | 42.49 | 270.88 | 190.30 | 42.34 | 270.88 | 190.30 | 42.34 |
| PBT | 158.65 | 163.69 | -3.08 | 548.06 | 693.47 | -20.97 | 548.06 | 693.47 | -20.97 |
| TAX | 12.99 | 34.79 | -62.66 | 125.85 | 194.24 | -35.21 | 125.85 | 194.24 | -35.21 |
| Deferred Tax | -35.01 | 8.10 | -532.22 | 3.66 | 73.35 | -95.01 | 3.66 | 73.35 | -95.01 |
| PAT | 145.66 | 128.90 | 13.00 | 422.21 | 499.23 | -15.43 | 422.21 | 499.23 | -15.43 |
| Equity | 820.55 | 820.55 | 0.00 | 820.55 | 820.55 | 0.00 | 820.55 | 820.55 | 0.00 |
| PBIDTM(%) | 19.78 | 21.96 | -9.91 | 19.07 | 22.56 | -15.46 | 19.07 | 22.56 | -15.46 |
Read More
May
19
2026
Posted on May 19th 2026
Fortis MalarHospital - Quaterly Results
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended March 2026, as compared to corresponding quarter of last year.The Net Loss for the quarter ended March 2026 is Rs. -0.30 millions as compared to Net Profit of Rs. 3.61 millions of corresponding quarter ended March 2025A decline of 1.22 millions was observed in the OP in the quarter ended March 2026 from 3.97 millions on QoQ basis.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 6.56 | 7.67 | -14.47 | 63.02 | 27.17 | 131.95 | 63.02 | 27.17 | 131.95 |
| PBIDT | 1.22 | 3.97 | -69.27 | 47.91 | 5.95 | 705.21 | 47.91 | 5.95 | 705.21 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 | 0.00 | 0.10 | 0.00 |
| PBDT | 1.22 | 3.97 | -69.27 | 47.91 | 5.85 | 718.97 | 47.91 | 5.85 | 718.97 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBT | 1.22 | 3.97 | -69.27 | 47.91 | 5.85 | 718.97 | 47.91 | 5.85 | 718.97 |
| TAX | 1.52 | 0.36 | 322.22 | 5.89 | 1.76 | 234.66 | 5.89 | 1.76 | 234.66 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | -0.30 | 3.61 | -108.31 | 42.02 | 4.09 | 927.38 | 42.02 | 4.09 | 927.38 |
| Equity | 187.57 | 187.57 | 0.00 | 187.57 | 187.57 | 0.00 | 187.57 | 187.57 | 0.00 |
| PBIDTM(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Read More
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Amkay Products Ltd. is ₹54.00 as of 2026-05-18.
The market capitalisation of Amkay Products Ltd. is ₹46.74 as of 2026-05-18.
The 1-year return of Amkay Products Ltd. is 8.50% as of 2026-05-18.
The P/E ratio of Amkay Products Ltd. is 10.31 as of 2026-05-19.
The 52-week high and low of Amkay Products Ltd. are ₹81.99 and ₹36.50, respectively, as of 2026-05-18.
View More
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
Home
Shopping
Loan Offers
My Accounts
Explore
